| Bioactivity | Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1]. |
| Name | Nelipepimut-S |
| CAS | 160212-35-1 |
| Shortening | KIFGSLAFL |
| Formula | C50H78N10O11 |
| Molar Mass | 995.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press). 2020 Apr 3;12:69-75. |
Nelipepimut-S
CAS: 160212-35-1 F: C50H78N10O11 W: 995.21
Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast ca
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.